The Occurrence of Philadelphia Chromosome (Ph) Negative Leukemia after Hematopoietic Stem Cell Transplantation for Ph Positive Chronic Myeloid Leukemia: Implications for Disease Monitoring and Treatment

References

• Vardiman, LW., Imbed, M., Pierre, R., Thiele, J., Brunning, RD. and Flandrin, G. (2001) "Chronic myelogenous leukaemia", In: Jaffe, ES., Harris, N.L., Stein, H. and Vardiman,eds, Tumours ofHaematopoietic and Lymphoid Tissues, World Health Organization Classification of Tumors 2001 (IARC Press, Lyon), pp. 20–26.
   Google Scholar
• Goldman, J.M. and Druker, B.J. (2001) "Chronic myeloid leukemia: current treatment options", Blood 98(7), 2039–2042.
   Web of Science ®Google Scholar
• Appelbaum, F.R. (2001) "Perspectives on the future of chronic myeloid leukemia treatment", Semin. Hematol. 38(3 Suppl. 8), 35–42.
   PubMed Web of Science ®Google Scholar
• Silver, R.T., Woolf, S.H., Hehlmann, R., Appelbaum, FR., Anderson, J., Bennett, C., et al. (1999) "An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon, and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemia: developed for the American Society of Hematology", Blood 94(5), 1517–1536.
   PubMed Web of Science ®Google Scholar
• Collins, Jr, R.H., Shpilberg, 0., Drobyski, W.R., Porter, DL., Giralt, S., Champlin, R., et al. (1997) "Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation", J. Clin. Oncol. 15(2), 433–444.
   PubMed Web of Science ®Google Scholar
• Childs, R., Epperson, D., Bahceci, E., Clave, E. and Barrett, J. (1999) "Molecular remission of chronic myeloid leukaemia following a non-myeloablative allogeneic peripheral blood stem cell transplant: in vivo and in vitro evidence for a graft-versus-leukaemia effect", Br J. Haematol. 107(2), 396–400.
   Web of Science ®Google Scholar
• Hansen, LA., Gooley, TA., Martin, P.J., Appelbaum, F., Chauncey, T.R., Clift, R.A., et al. (1998) "Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia", N. Engl. J. Med. 338(14), 962–968.
   Google Scholar
• Craddock, C., Szydlo, R.M., Klein, IP., Dazzi, F., Olavarria, E., van Rhee, F., et al. (2000) "Estimating leukemia-free survival after allografting for chronic myeloid leukemia: a new method that takes into account patients who relapse and are restored to complete remission", Blood 96(1), 86–90.
   PubMed Web of Science ®Google Scholar
• Gratwohl, A., Hermans, J., Goldman, J.M., Arcese, W., Carreras, E., Devergie, A., et al. (1998) "Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation", Lancet 352(9134), 1087–1092.
   Google Scholar
• Bacigalupo, A., Gualandi, F., Van Lint, MT., Sessarego, M., Frassoni, F., Occhini, D., et al. (1993) "Multivariate analysis of risk factors for survival and relapse in chronic granulocytic leukemia following allogeneic marrow transplantation: impact of disease related variables (Sokal score)", Bone Marrow Transplant. 12(5), 443–448.
   PubMed Web of Science ®Google Scholar
• Konstantinidou, P., Szydlo, R.M., Chase, A. and Goldman, J.M. (2000) "Cytogenetic status pre-transplant as a predictor of outcome post bone marrow transplantation for chronic myelogenous leukaemia", Bone Marrow Transplant. 25(2), 143–146.
   PubMed Web of Science ®Google Scholar
• Drobyski, W.R., Hessner, M.J., Klein, LP., Kabler-Babbitt, C., Vesole, D.H., Margolis, D.A., et al. (1999) "T-cell depletion plus salvage immunotherapy with donor leukocyte infusions as a strategy to treat chronic-phase chronic myelogenous leukemia patients undergoing HLA-identical sibling marrow transplan-tation", Blood 94(2), 434–441.
   PubMed Web of Science ®Google Scholar
• Barrett, A.J., Ringden, 0., Zhang, M.J., Bashey, A., Cahn, J.Y., Cairo, MS., et al. (2000) "Effect of nucleated marrow cell dose on relapse and survival in identical twin bone marrow transplants for leukemia", Blood 95(11), 3323–3327.
   PubMed Web of Science ®Google Scholar
• Enright, H., Davies, S.M., DeFor, T., Shu, X., Weisdorf, D., Miller, W., et al. (1996) "Relapse after non-T-cell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: early transplantation, use of an unrelated donor, and chronic graft-versus-host disease are protective", Blood 88(2), 714–720.
   PubMed Web of Science ®Google Scholar
• van Rhee, F., Szydlo, R.M., Hermans, J., Devergie, A., Frassoni, F., Arcese, W., et al. (1997) "Long-term results after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase: a report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation", Bone Marrow Transplant. 20(7), 553–560.
   PubMed Web of Science ®Google Scholar
• Kaeda, J., Chase, A. and Goldman, J.M. (2002) "Cytogenetic and molecular monitoring of residual disease in chronic myeloid leukaemia", Acta Haematol. 107(2), 64–75.
   PubMed Web of Science ®Google Scholar
• Radich,Gooley, T., Bryant, E., Chauncey, T., Clift, R., Beppu,L., et al. (2001) "The significance of bcr-abl molecular detection in chronic myeloid leukemia patients late 18 months or more after transplantation", Blood 98(6), 1701–1707.
   Google Scholar
• Zhang, M.J., Baccarani, M., Gale, R.P., McGlave, P.B., Atkinson, K., Champlin, RE., et al. (1997) "Survival of patients with chronic myelogenous leukaemia relapsing after bone marrow transplan-tation: comparison with patients receiving conventional chemother-apy", Br. J. Haematol. 99(1), 23–29.
   Web of Science ®Google Scholar
• Kurzrock, R., Kantarjian, H.M., Shtalrid, M., Gutterman, J.U. and Talpaz, M. (1990) "Philadelphia chromosome-negative chronic myelogenous leukemia without breakpoint cluster region rearrange-ment: a chronic myeloid leukemia with a distinct clinical course", Blood 75(2), 445–452.
   PubMed Web of Science ®Google Scholar
• Shtalrid, M., Talpaz, M., Blick, M., Romero, P., Kantarjian, H., Taylor, K., et al. (1988) "Philadelphia-negative chronic myelogen-ous leukemia with breakpoint cluster region rearrangement: molecular analysis, clinical characteristics, and response to therapy", J. Clin. Oncol. 6(10), 1569–1575.
   Web of Science ®Google Scholar
• Chomel, J.C., Brizard, F., Veinstein, A., Rivet, J., Sadoun, A., Kitzis, A., et al. (2000) "Persistence of BCR-ABL genomic rearrangement in chronic myeloid leukemia patients in complete and sustained cytogenetic remission after interferon-alpha therapy or allogeneic bone marrow transplantation", Blood 95(2), 404–408.
   PubMed Web of Science ®Google Scholar
• Costello, R., Sainty, D., Lafage Pochitaloff, M. and Gabert, J. (1997) "Clinical and biological aspects of Philadelphia-negative/ BCR-negative chronic myeloid leukemia", Leuk. Lymphoma 25(3-4), 225–232.
   PubMed Web of Science ®Google Scholar
• Branford, S., Rudzld, Z. and Hughes, T.P. (2000) "A novel BCR-ABL transcript (e8a2) with the insertion of an inverted sequence of ABL intron lb in a patient with Philadelphia-positive chronic myeloid leukaemia", Br. J. Haematol. 109(3), 635–637.
   Web of Science ®Google Scholar
• Mughal, TI., Yong, A., Szydlo, R.M., Dazzi, F., Olavarria, E., van Rhee, F., et al. (2001) "Molecular studies in patients with chronic myeloid leukaemia in remission 5 years after allogeneic stem cell transplant define the risk of subsequent relapse", Br. J. Haematol. 115(3), 569–574.
   Web of Science ®Google Scholar
• Serrano, J., Roman, J., Sanchez, J., Jimenez, A., Castillejo, J.A., Herrera, C., et al. (2000) "Molecular analysis of lineage-specific chimerism and minimal residual disease by RT-PCR of p210(BCR-ABL) and p190(BCR-ABL) after allogeneic bone marrow transplantation for chronic myeloid leukemia: increasing mixed myeloid chimerism and p190(BCR-ABL) detection precede cytogenetic relapse", Blood 95(8), 2659–2665.
   PubMed Web of Science ®Google Scholar
• Au, WY., Chan, AC. and Kwong, Y.L. (1999) "Isolated lymph node T lymphoblastic transformation of chronic myeloid leukemia during interferon treatment", Am. J. Hematol. 62(4), 256–258.
   PubMed Web of Science ®Google Scholar
• Kiss, T.L., Abdolell, M., Jamal, N., Minden, M.D., Lipton, J.H. and Messner, H.A. (2002) "Long-term medical outcomes and quality-of-life assessment of patients with chronic myeloid leukemia followed at least 10 years after allogeneic bone marrow transplantation", J. Clin. Oncol. 20(9), 2334–2343.
   Web of Science ®Google Scholar
• Cullis, J.0., Marks, DJ., Schwarer, A.P., Barrett, A.J., Hows, J.M., Swirsky, D.M., et al. (1992) "Relapse into blast crisis following bone marrow transplantation for chronic phase chronic myeloid leukaemia: a report of five cases", Br. J. Haematol. 81(3), 378–382.
   PubMed Web of Science ®Google Scholar
• Au, WY., Chan, AC., Lie, AK., So, J.C., Liang, R. and Kwong, Y.L. (1998) "Isolated extramedullary relapse after allogeneic bone marrow transplantation for chronic myeloid leukemia", Bone Marrow Transplant. 22(1), 99–102.
   PubMed Web of Science ®Google Scholar
• Au, WY., Lie, AK., Ma, S.K., Wan, T.S., Liang, R., Chan, E.C., et al. (2002) "Tyrosine kinase inhibitor ST1571 in the treatment of Philadelphia chromosome-positive leukaemia failing myeloablative stem cell transplantation", Bone Marrow Transplant. 30(7), 453–457.
   PubMed Web of Science ®Google Scholar
• Lee, C.K., Lie, AK., Liang, R., Au, WY, Chen, FE., Chim, CS., et al. (1999) "Outcome of Chinese patients with chronic myeloid leukaemia (CML) who underwent allogeneic bone-marrow transplantation (BMT)", Am. J. Hematol. 61(2), 85–89.
   PubMed Web of Science ®Google Scholar
• Zaccaria, A., Rosti, G., Sessarego, M., Frassoni, F., Marmont, A., Galimberti, M., et al. (1988) "Relapse after allogeneic bone marrow transplantation for Philadelphia chromosome positive chronic myeloid leukemia: cytogenetic analysis of 24 patients", Bone Marrow Transplant. 3(5), 413–423.
   PubMed Web of Science ®Google Scholar
• Seong, D., Kantarjian, H.M., Albitar, M., Arlinghaus, R., Xu, J., Talpaz, M., et al. (1999) "Analysis of Philadelphia chromosome-negative BCR-ABL-positive chronic myelogenous leukemia by hypermetaphase fluorescence in situ hybridization", Ann. Oncol. 10(8), 955–959.
   Google Scholar
• Manley, R., Cochrane, J., McDonald, M., Rigby, S., Moore, A., Kirk, A., et al. (1999) "Clonally unrelated BCR-ABL-negative acute myeloblastic leukemia masquerading as blast crisis after busulphan and interferon therapy for BCR-ABL-positive chronic myeloid leukemia", Leukemia 13(1), 126–129.
   PubMed Web of Science ®Google Scholar
• Au, WY., Lie, A.K., Ma, S.K., Leung, Y.H., Siu, L.L. and Kwong, Y.L. (2001) "Therapy-related myelodysplastic syndrome of recipient origin after allogeneic bone marrow transplantation for acute lymphoblastic leukaemia", Br. J. Haematol. 112(2), 424–426.
   Web of Science ®Google Scholar
• Au, WY., Ma, S.K., Wan, T.S., Wang, E.P., Lau, T.C.M. and Kwong, Y.L. (2002) "Concurrent mediastinal B cell lymphoma and chronic myeloid leukemia with an unusually favorable response to chemotherapy", Leuk. Lymphoma, In press.
   Google Scholar
• Lowsky, R., Fyles, G., Minden, M., Lipton, J., Meharchand, J., Tejpar, I., et al. (1996) "Detection of donor cell derived acute myelogenous leukaemia in a patient transplanted for chronic myelogenous leukaemia using fluorescence in situ hybridization", Br J. Haematol. 93(1), 163–165.
   Web of Science ®Google Scholar
• Hambach, L., Eder, M., Dammann, E., Battmer, K., Stucki, A., Heil, G., et al. (2001) "Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia", Bone Marrow Transplant. 28(7), 705–707.
   PubMed Web of Science ®Google Scholar
• Abeliovich, D., Yehuda, 0., Nagler, A., Lerer, I., Ben Neriah, S., Amar, A., et al. (1996) "Predominant 45, X,—Y karyotype in donor cells after allogeneic BMT: cytogenetic and molecular analysis", Cancer Genet. Cytogenet. 86(1), 1–7.
   PubMed Web of Science ®Google Scholar
• Marmont, A., Frassoni, F., Bacigalupo, A., Podesta, M., Piaggio, G., Van Lint, M.T., et al. (1984) "Recurrence of Ph'-positive leukemia in donor cells after marrow transplantation for chronic granulocytic leukemia", N. Engl. J. Med. 310(14), 903–906.
   Google Scholar
• McCann, S.R., Lawler, M. and Bacigalupo, A. (1993) "Recurrence of Philadelphia chromosome-positive leukemia in donor cells after bone marrow transplantation for chronic granulocytic leukemia", Leuk. Lymphoma 10(6), 419–425.
   PubMed Web of Science ®Google Scholar
• Saito, Y, Uzuka, Y., Sakai, N., Suzuki, S. and Toyota, T. (2000) "A Philadelphia chromosome positive acute lymphoblastic leukemia of donor origin after allogeneic bone marrow transplan-tation for chronic myelogenous leukemia in chronic phase", Bone Marrow Transplant. 25(11), 1209–1211.
   PubMed Web of Science ®Google Scholar
• Au, WY., Chan, E.C., Siu, L.L.P., Lau, T.C., Lie, A.K.W., Ma, S.K. and Kwong, Y.L. (2002) "Leukaemic relapse of donor origin after allogeneic bone marrow transplantation from a donor who later developed bronchogenic carcinoma", Br. J. Haematol. 119, 777–780.
   PubMed Web of Science ®Google Scholar
• Cooley, L.D., Sears, D.A., Udden, M.M., Harrison, W.R. and Baker, K.R. (2000) "Donor cell leukemia: report of a case occurring 11 years after allogeneic bone marrow transplantation and review of the literature", Am. J. Hematol. 63(1), 46–53.
   PubMed Web of Science ®Google Scholar
• Gopcsa, L., Barta, A., Banyai, A., Konya, M., Pajor, L., Foldi, J., et al. (2002) "Acute myeloid leukaemia of donor cell origin developing 5 years after allogeneic bone marrow transplantation for chronic myeloid leukaemia", Bone Marrow Transplant. 29(5), 449–452.
   PubMed Web of Science ®Google Scholar
• Smith, J.L., Heerema, N.A. and Provisor, A.J. (1985) "Leukaemic transformation of engrafted bone marrow cells", Br J. Haematol. 60(3), 415–422.
   Web of Science ®Google Scholar
• Niederwieser, D.W., Appelbaum, F.R., Gastl, G., Gersdorf, E., Meister, B., Geissler, D., et al. (1990) "Inadvertent transmission of a donor's acute myeloid leukemia in bone marrow transplantation for chronic myelocytic leukemia", N. Engl. J. Med. 322(25), 1794–1796.
   Google Scholar
• Turhan, A.G., Humphries, R.K., Phillips, G.L., Eaves, A.C. and Eaves, C.J. (1989) "Clonal hematopoiesis demonstrated by X-linked DNA polymorphisms after allogeneic bone marrow transplantation", N. Engl. J. Med. 320(25), 1655–1661.
   Google Scholar
• Arthur, C.K., Apperley, J.F., Guo, A.P., Rassool, F., Gao, L.M. and Goldman, J.M. (1988) "Cytogenetic events after bone marrow transplantation for chronic myeloid leukemia in chronic phase", Blood 71(5), 1179–1186.
   PubMed Web of Science ®Google Scholar
• van den Berg, H., Beverstock, G., Westerhof, J.P. and Vossen, J.M. (1991) "Chromosomal studies after bone marrow transplantation for leukaemia in children", Bone Marrow Transplant. 7(5), 335–342.
   PubMed Web of Science ®Google Scholar
• Williams, S.V., Williams, J., Barnard, D.L. and Mason, M.K. (1992) "Appearance of Ph negative recipient clones in chronic myeloid leukemia patients following bone marrow transplantation", Cancer Genet. Cytogenet. 58(2), 143–151.
   Google Scholar
• Goldman, J.M. and O'Brien, S.G. (1993) "Residual Ph-negative stem cells in chronic myeloid leukemia—sometimes or always?", Stem Cells 11\(Suppl. 3), 4–7.
   PubMed Web of Science ®Google Scholar
• Singer, I.O., Franklin, I.M., Clark, R.E., Chalmers, E.A., Kelsey, S.M., Newland, A.C., et al. (1998) "Autologous transplantation in chronic myeloid leukaemia using peripheral blood stem cells", Br J. Haematol. 102(5), 1359–1362.
   Google Scholar
• Barnett, M.J., Eaves, C.J., Phillips, G.L., Kalousek, D.K., Klingemann, HG., Lansdorp, P.M., et al. (1989) "Successful autografting in chronic myeloid leukaemia after maintenance of marrow in culture", Bone Marrow Transplant. 4(4), 345–351.
   PubMed Web of Science ®Google Scholar
• Brunstein, C.G., Hirsch, B.A., Miller, J.S., McGlennen, R.C., Verfaillie, CM., McGlave, P.B., et al. (2000) "Non-leukemic autologous reconstitution after allogeneic bone marrow transplan-tation for Ph-positive chronic myelogenous leukemia: extended remission preceding eventual relapse", Bone Marrow Transplant. 26(11), 1173–1177.
   PubMed Web of Science ®Google Scholar
• Fouillard, L., Deconinck, E., Tiberghien, P., Deschaseaux, ML., Solary, E., Mugneret, F., et al. (1998) "Prolonged remission and autologous recovery in two patients with chronic myelogenous leukemia after graft failure of allogeneic bone marrow transplan-tation", Bone Marrow Transplant. 21(9), 943–946.
   PubMed Web of Science ®Google Scholar
• Raskind, W.H., Ferraris, A.M., Najfeld, V, Jacobson, R.J., Moohr, J.W. and Fialkow, P.J. (1993) "Further evidence for the existence of a clonal Ph-negative stage in some cases of Ph-positive chronic myelocytic leukemia", Leukemia 7(8), 1163–1167.
   PubMed Web of Science ®Google Scholar
• Fialkow, P.J., Martin, P.J., Najfeld, V, Penfold, G.K., Jacobson, R.J. and Hansen, J.A. (1981) "Evidence for a multistep pathogenesis of chronic myelogenous leukemia", Blood 58(1), 158–163.
   PubMed Web of Science ®Google Scholar
• Ferraris, A.M., Canepa, L., Melani, C., Miglino, M., Broccia, G. and Gaetani, G.F. (1989) "Clonal B lymphocytes lack bcr rearrangement in Ph-positive chronic myelogenous leukaemia", Br J. Haematol. 73(1), 48–50.
   Web of Science ®Google Scholar
• Ariyama, T., Inazawa, J., Uemura, Y, Kakazu, N., Maekawa, T., Urase, R, et al. (1995) "Clonal origin of Philadelphia chromosome negative cells with trisomy 8 appearing during the course of alpha-interferon therapy for Ph positive chronic myelocytic leukemia", Cancer Genet. Cytogenet. 81(1), 20–23.
   Google Scholar
• Fayad, L., Kantarjian, H., O'Brien, S., Seong, D., Albitar, M., Keating, M., et al. (1997) "Emergence of new clonal abnormalities following interferon-alpha induced complete cytogenetic response in patients with chronic myeloid leukemia: report of three cases", Leukemia 11(5), 767–771.
   PubMed Web of Science ®Google Scholar
• Andersen, M.K., Pedersen-Bjergaard, J., Kjeldsen, L., Dufva, I.H. and Brondum-Nielsen, K. (2002) "Clonal Ph-negative hematopoie-sis in CML after therapy with imatinib mesylate is frequently characterized by trisomy 8", Leukemia 16(7), 1390–1393.
   PubMed Web of Science ®Google Scholar
• Braziel, R.M., Launder, TM., Druker, B.J., Olson, S.B., Magenis, RE., Mauro, M.J., et al. (2002) "Hematopathologic and cytogenetic findings in imatinib mesylate-treated chronic myelogenous leukemia patients: 14 months' experience", Blood 100(2), 435–441.
   PubMed Web of Science ®Google Scholar
• Flamm, M.J., Murty, V.V., Rao, P.H. and Nichols, G.L. (2002) "Coexistence of independent myelodysplastic and Philadelphia chromosome positive clones in a patient treated with hydroxyurea", Leuk. Res. 26(4), 417–420.
   Google Scholar
• Dawson, L., Slater, R., Hagemeijer, A., Langerak, A.W., Willemze, R. and Kluin-Nelemans, J.C. (1999) "Secondary T-acute lympho-blastic leukaemia mimicking blast crisis in chronic myeloid leukaemia", Br. J. Haematol. 106(1), 104–106.
   Google Scholar
• Krishnan, A., Bhatia, S., Slovak, ML., Arber, D.A., Niland, J.C., Nademanee, A., et al. (2000) "Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors", Blood 95(5), 1588–1593.
   PubMed Web of Science ®Google Scholar
• Johansson, B., Fioretos, T. and Mitehnan, F. (2002) "Cytogenetic and molecular genetic evolution of chronic myeloid leukemia", Acta Haematol. 107(2), 76–94.
   PubMed Web of Science ®Google Scholar
• Offit, K., Burns, IP., Cunningham, I., Jhanwar, S.C., Black, P., Kernan, NA., et al. (1990) "Cytogenetic analysis of chimerism and leukemia relapse in chronic myelogenous leukemia patients after T cell-depleted bone marrow transplantation", Blood 75(6), 1346–1355.
   PubMed Web of Science ®Google Scholar
• Schmitz, N., Schlegelberger, B., Oberboster, K., Golchert, K., Suttorp, M. and Loft'ler, H. (1991) "Lymphohaematopoietic chimaerism after bone marrow transplantation for chronic myeloid leukaemia: results of simultaneous cytogenetic analyses on T-cell colonies, myeloid, and erythroid progenitor cells", Br J. Haematol. 78(3), 334–342.
   PubMed Web of Science ®Google Scholar
• Au, WY., Lie, AK., Ma, S.K., Wan, T.S., Liang, R., Leung, Y.H., et al. (2001) "Philadelphia (Ph) chromosome-positive chronic myeloid leukaemia relapsing as Ph-negative leukaemia after allogeneic bone marrow transplantation", Br J. Haematol. 114(2), 365–368.
   Web of Science ®Google Scholar